Wilson's disease: Long-term follow-up of a cohort of 24 patients treated with D-penicillamine

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 5, 2010, Pages 564-571

  Lowette, Klaartje F ^a   Desmet, Koen ^a   Witters, Peter ^a   Laleman, Wim ^a   Verslype, Chris ^a   Nevens, Frederik ^a   Fevery, Johan ^a   Cassiman, David M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

D penicillamine; Outcome; Wilson's disease

Indexed keywords

PENICILLAMINE; ZINC ACETATE;

ACNE; ADULT; AGITATION; AMENORRHEA; ARTICLE; BRADYKINESIA; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COPPER BLOOD LEVEL; DEPRESSION; DIAGNOSTIC ACCURACY; DISEASE COURSE; DIZZINESS; DRUG WITHDRAWAL; DYSARTHRIA; DYSKINESIA; DYSTONIA; FEMALE; FOLLOW UP; HUMAN; KIDNEY DISEASE; LEUKOPENIA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER GRAFT; LONG TERM CARE; MALE; NEPHROTIC SYNDROME; NEUROLOGIC DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEINURIA; PRURITUS; RASH; REFLEX DISORDER; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SKIN DEFECT; SPONTANEOUS ABORTION; STEATOSIS; SURVIVAL RATE; THROMBOCYTOPENIA; TREMOR; VOMITING; WEIGHT GAIN; WILSON DISEASE;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CARCINOMA, HEPATOCELLULAR; CHELATING AGENTS; CHILD; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; NERVOUS SYSTEM DISEASES; PATIENT COMPLIANCE; PENICILLAMINE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951268052     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283353df8     Document Type: Article

References (17)

1. Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 2006; 120:151-159.
2. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003; 23:139-142.
3. Brewer GJ, Askari FK. Wilson's disease: clinical management and therapy. J Hepatol 2005; 42 (Suppl 1):S13-S21.
4. Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson disease - a cohort study. Gut 2007; 56:115-120.
5. Takeshita Y, Shimizu N, Yamaguchi Y, Nakazono H, Saitou M, Fujikawa Y, Aoki T. Two families with Wilson disease in which siblings showed different phenotypes. J Hum Genet 2002; 47:543-547.
6. Durand F. Wilson's disease: an old disease keeps its old secrets. Eur J Gastroenterol Hepatol 2007; 19:97-99.
7. Kumagi T, Horiike N, Michitaka K, Hasebe A, Kawai K, Tokumoto Y, et al. Recent clinical features of Wilson's disease with hepatic presentation. J Gastroenterol 2004; 39:1165-1169.
8. Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology 2005; 41:668-670.
9. Das SK, Ray K. Wilson's disease: an update. Nat Clin Pract Neurol 2006; 2:482-493.
10. Ferenci P. Pathophysiology and clinical features of Wilson disease. Metab Brain Dis 2004; 19:229-239.
11. Langner C, Denk H. Wilson disease. Virchows Arch 2004; 445:111-118.
12. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007; 369:397-408.
13. Walshe JM. Cause of death in Wilson disease. Mov Disord 2007; 22:2216-2220.
14. Walshe JM. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med 1973; 42:441-452.
15. Brewer GJ, Terry CA, Aisen AM, Hill GM.Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 1987; 44:490-493.
16. Medici V, Rossaro L, Sturniolo GC. Wilson disease-a practical approach to diagnosis, treatment and follow-up. Dig Liver Dis 2007; 39:601-609.
17. Ferenci P. Review article: diagnosis and current therapy ofWilson's disease. Aliment Pharmacol Ther 2004; 19:157-165.